Literature DB >> 18615634

NMR characterization of the host-guest inclusion complex between beta-cyclodextrin and doxepin.

Jennifer R Cruz1, Bridget A Becker, Kevin F Morris, Cynthia K Larive.   

Abstract

The interaction between doxepin, a member of the tricyclic antidepressant (TCA) class of drugs, with beta-cyclodextrin (beta-CD) was investigated using NMR. Several TCAs have been reported to form a complex with beta-CD having 1:1 stoichiometry. Previous results from UV-visible spectroscopy, fluorescence measurements, and molecular modeling indicated that for imipramine, desipramine, and amitriptyline, the TCA aliphatic tail is included in the cyclodextrin cavity with apparently no interaction of the tricyclic ring. An alternative view of the doxepin-beta-CD complex is presented in this work using analysis of complexation-induced chemical shifts (CICSs), the method of continuous variation (Job's analysis), and analysis of ROESY spectra. The Job's plot derived from the NMR spectral data confirms that the complex formed has 1:1 stoichiometry. The largest changes in the CICS data were observed for the aromatic protons of one of the doxepin rings, with much smaller chemical shift changes observed for the protons of the other aromatic ring and the doxepin tail. Perhaps the most significant evidence for inclusion of the doxepin tricyclic ring is the strong ROESY cross peaks between the doxepin aromatic resonances and the protons located inside the beta-CD cavity. Changes in the doxepin (1)H NMR spectrum and the behavior of ROESY exchange cross peaks suggest that inclusion complex formation decreases the rate of internal motions of doxepin. 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18615634     DOI: 10.1002/mrc.2267

Source DB:  PubMed          Journal:  Magn Reson Chem        ISSN: 0749-1581            Impact factor:   2.447


  6 in total

1.  Molecular recognition and enhancement of aqueous solubility and bioactivity of CD437 by β-cyclodextrin.

Authors:  Robert J Mishur; Matthew E Griffin; Cooper H Battle; Bin Shan; Janarthanan Jayawickramarajah
Journal:  Bioorg Med Chem Lett       Date:  2010-11-21       Impact factor: 2.823

2.  Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.

Authors:  Sampada B Upadhye; Swapnil J Kulkarni; Soumyajit Majumdar; Mitchell A Avery; Waseem Gul; Mahmoud A ElSohly; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

3.  Sodium cholate aggregation and chiral recognition of the probe molecule (R,S)-1,1'-binaphthyl-2,2'-diylhydrogenphosphate (BNDHP) observed by 1H and 31P NMR spectroscopy.

Authors:  Christine M Hebling; Laura E Thompson; Kyle W Eckenroad; Gregory A Manley; Roderick A Fry; Karl T Mueller; Timothy G Strein; David Rovnyak
Journal:  Langmuir       Date:  2008-12-16       Impact factor: 3.882

4.  Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia.

Authors:  Srinivasa M Sammeta; Siva Ram K Vaka; S Narasimha Murthy
Journal:  J Control Release       Date:  2009-11-14       Impact factor: 9.776

5.  New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles.

Authors:  Mariangela de Burgos M de Azevedo; Ljubica Tasic; Juliana Fattori; Fábio H S Rodrigues; Fabiana C Cantos; Leandro P Ribeiro; Vanice de Paula; Danielle Ianzer; Robson A S Santos
Journal:  Int J Nanomedicine       Date:  2011-05-15

6.  Interactions between 4-thiothymidine and water-soluble cyclodextrins: Evidence for supramolecular structures in aqueous solutions.

Authors:  Vito Rizzi; Sergio Matera; Paola Semeraro; Paola Fini; Pinalysa Cosma
Journal:  Beilstein J Org Chem       Date:  2016-03-21       Impact factor: 2.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.